We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
-8.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.03B
AUM Growth
-$263M
(-8%)
Cap. Flow
+$136M
Cap. Flow
% of AUM
4.51%
Top 10 Holdings %
Top 10 Hldgs %
30.94%
Holding
140
New
22
Increased
32
Reduced
18
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$46.4M |
| 2 |
Pool Corp
POOL
|
+$35.7M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$34.3M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$22M |
| 5 |
Lennox International
LII
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$26.6M |
| 2 |
Steel Dynamics
STLD
|
+$22.8M |
| 3 |
XPO
XPO
|
+$21.4M |
| 4 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$19.6M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.23% |
| 2 | Technology | 22.61% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Utilities | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Kiniksa Pharmaceuticals
KNSA
$6.1B
| – | – |
-37,807
| Closed | -$512K |
|
127
MacroGenics
MGNX
$240M
| – | – |
-485,000
| Closed | -$8.23M |
|
|
128
Steel Dynamics
STLD
$36.2B
| – | – |
-754,000
| Closed | -$22.8M |
|
129
Savara
SVRA
$1.14B
| – | – |
-1,400,000
| Closed | -$3.32M |
|
|
MIC
130
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| – | – |
-289,000
| Closed | -$11.7M |
|
|
TLND
131
DELISTED
Talend S.A. American Depositary Shares
TLND
| – | – |
-690,000
| Closed | -$26.6M |
|
|
PS
132
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| – | – |
-645,000
| Closed | -$19.6M |
|
|
UROV
133
DELISTED
Urovant Sciences Ltd.
UROV
| – | – |
-401,558
| Closed | -$3.18M |
|
|
IMMU
134
DELISTED
Immunomedics Inc
IMMU
| – | – |
-966,000
| Closed | -$13.4M |
|
|
LPT
135
DELISTED
Liberty Property Trust
LPT
| – | – |
-10,500
| Closed | -$525K |
|
|
MDCO
136
DELISTED
Medicines Co
MDCO
| – | – |
-335,000
| Closed | -$12.2M |
|
|
APU
137
DELISTED
AmeriGas Partners, L.P.
APU
| – | – |
-33,000
| Closed | -$1.15M |
|
Similar funds
HPG
EMPI
RCG
JWBC
AAM
AA
CM
CIS
Eventide Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Eventide Asset Management held 140 positions worth $3.03B, down 8% from $3.29B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Eventide Asset Management deployed $136M of net new capital in Q3 2019, opening 22 new positions and adding to 32 existing holdings. Its largest new stake was Smartsheet Inc.: 975,000 shares worth $35.1M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was XPO, an estimated $21.4M trimmed.
- Eventide Asset Management's largest Q3 2019 buy was Smartsheet Inc.: 975,000 shares worth $35.1M.
- Eventide Asset Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $34.3M increase.
- Eventide Asset Management's biggest Q3 2019 reduction was XPO, cutting an estimated $21.4M.
- Eventide Asset Management fully exited Talend S.A. American Depositary Shares in Q3 2019, selling an estimated $26.6M.
- Eventide Asset Management's ten largest holdings make up 31% of its $3.03B portfolio in Q3 2019.
- Eventide Asset Management opened 22 new positions and closed 16 in Q3 2019.
- Eventide Asset Management's portfolio value fell 8% quarter-over-quarter to $3.03B.
Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.